U.S. Teleradiology Market (By Product: X-rays, CT Scans, MRI Scans, Nuclear Imaging, Ultrasound; By Type: Preliminary Tests, Final Tests; By End-use) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2023-2032

The U.S. teleradiology market was surpassed at USD 0.88 billion in 2022 and is expected to hit around USD 2.77 billion by 2032, growing at a CAGR of 12.16% from 2023 to 2032.

U.S. Teleradiology Market Size 2023 to 2032

Key Pointers

  • The X-rays segment held the largest revenue share of 29% in 2022. 
  • The market for CT scans is expected to expand at the highest CAGR of 12.83% during the forecast period. 
  • The preliminary tests segment held the largest revenue share above 64% in 2022. 
  • The final tests segment is anticipated to exhibit the fastest CAGR of 13.24% from 2023 to 2032. 
  • The hospitals segment held the largest market share of approximately 53% in 2022. 
  • The radiology clinics segment is anticipated to exhibit a CAGR of 12.54% from 2023 to 2032.

Report Scope of the U.S. Teleradiology Market

Report Coverage Details
Market Size in 2022 USD 0.88 billion
Revenue Forecast by 2032 USD 2.77 billion
Growth rate from 2023 to 2032 CAGR of 12.16%
Base Year 2022
Forecast Period 2023 to 2032
Market Analysis (Terms Used) Value (US$ Million/Billion) or (Volume/Units)
Companies Covered Virtual Radiologic (vRad); Agfa-Gevaert Group; ONRAD, Inc.; Everlight Radiology; 4ways Healthcare Ltd.; RamSoft, Inc.; USARAD Holdings, Inc.; Koninklijke Philips N.V.; Matrix (Teleradiology Division of Radiology Partners); Medica Group PLC


The increase in imaging surgical procedures, development of information technology, increasing expenses of healthcare, and rising incidence of arthritis and chronic diseases are among the main drivers of the expansion of the market. The rise in teleradiology is attributed to the demand for additional opinions and emergencies, as well as the rising prevalence of the target diseases, which are the main drivers of market growth. The COVID-19 pandemic added value to the teleradiology field.

The adoption of teleradiology systems is being driven by the lack of healthcare specialists, particularly in sub-specialty areas such as pediatrics, neurology, and muscles and joints radiology. This is because teleradiology enables these medical practitioners to view patient data from any location, enhancing diagnostic coverage. Therefore, it is expected that the market will rise over the forecast period due to the growing acceptance of teleradiology for early diagnosis.

The increasing healthcare expenditure and advancements in the teleradiology sector with the expansion of the business portfolio spur the market. Moreover, the increasing recruitment for the teleradiology department drives the market growth. For instance, in August 2023, one of the top physician-owned radiology practices in the nation, US Radiology Specialists, is determined to start hiring for the United States Radiology Connexia, an emerging teleradiology business, created to offer high-quality options for remote employment that satisfy the changing needs of radiologists at different career stages. As the need for outpatient imaging grows across US Radiology's nationwide network of medical practices and imaging facilities, securing access to subspecialized radiologists will be essential in maintaining the highest level of patient care. Connexia aims to transform the teleradiology market and promote ongoing expansion across US Radiology with a dedication to clinical excellence, a connection to a top national radiology organization, and a strong technical support infrastructure.

The market is growing due to the increased use of advanced imaging devices for diagnostic imaging. For instance, the American Cancer Society projects that in 2023, approximately 1,958,310 new cases of cancer and 609,820 cancer-related deaths are expected in the United States. This highlights the need for precise diagnosis, which can help healthcare providers in offering accurate surgical or non-surgical treatment. The rise in demand for clinical diagnostic imaging is therefore predicted to support the growth of the market over the forecast period. Non-invasive imaging methods, which are used to diagnose a variety of disorders, are included in teleradiology. These modalities include X-ray nuclear imaging, MRIs, ultrasounds, and CT scans. In addition, teleradiology helps with early disease detection, which in turn aids in efficient treatment.

Teleradiology applications such as telemonitoring, teleconsultation, and telediagnosis make it easier for radiologists to perform their daily activities efficiently. Global cloud networks, real-time interpretation, and effective on-site solutions are all provided via teleradiology. Both the incidence of emergencies in less developed areas and the prevalence of chronic diseases, including osteomyelitis, breast cancer, and cellulitis are expected to increase. For instance, 297,790 women are estimated to receive an invasive breast cancer diagnosis in the United States in 2023, compared to 55,720 women who will receive an in situ, non-invasive breast cancer diagnostic. Invasive breast cancer incidence in women has increased annually by approximately 0.5% since the mid-2000s.

The implementation of beneficial government efforts, such as the United States Health Insurance Portability and Accountability Act of 1996, ensures that all data pertaining to patient health and personal information is completely safeguarded from cybercrimes. As a result, this Act must be followed by each teleradiology facility throughout the United States. Such measures boost physician and patient trust in teleradiology services, increasing their use over the anticipated period. Similar to this, the availability of healthcare coverage over the use of teleradiology services in nations like the United States and Australia is also anticipated to promote market growth.

Product Insights

Based on product, the market is segmented into X-rays, CT scans, MRI scans, ultrasound, and nuclear imaging. The X-rays segment held the largest revenue share of 29% in 2022. The segment's dominance is due to its lower cost, high utilization in primary diagnosis, and the advent of cutting-edge equipment such as filmless x-ray scanners. In addition, this method has a wide range of applications in the fields of chest imaging, orthopedics, heart diagnostics, cancer diagnosis, and dentistry imaging.

The advancements in the X-ray system and the cost-effective availability of the devices boost the industry growth. For instance, in July 2022, at the European Congress of Radiology held in Vienna, Siemens Healthineers introduced Mobilett Impact, its most recent mobile X-ray equipment. All the advantages of a transportable X-ray system for scanning at the patient's bedside were combined with complete digital functionality, an affordable price, and the following features: With Mobilett Impact, the whole imaging workflow-not just the imaging itself-can be completed at the patient's bedside.

The market for CT scans is expected to expand at the highest CAGR of 12.83% during the forecast period. This imaging technique's key advantage is that it makes it possible to image soft tissues, blood vessels, and bones in great detail. Additionally, this service is inexpensive, takes less time, and is more available than other modalities. With a greater focus being placed on cancer prevention and early diagnosis, several population-level screening programs are being created, and CT is predominantly employed as part of the lung health check program. The expansion of CT is facilitated by the delivery of quicker and sharper images of intricate body parts like the brain, heart cavities, and lungs. The increase in the demand for CT scans in the country is anticipated to create lucrative market growth opportunities.

Type Insights

Based on type, the market is segmented into preliminary tests and final tests. The preliminary tests segment held the largest revenue share above 64% in 2022. It involves the electronic transfer of the diagnostic images from the medical center to a remote radiologist who can immediately examine the photos and offer preliminary findings. In situations where time is critical, such as trauma cases or urgent procedures, this might be extremely important. As preliminary tests may be produced more quickly and cheaply than final reports, they are frequently used in emergency treatment. In hospitals and imaging facilities after-hours, providers receive better insurance reimbursement. Consequently, a quicker pace of growth is projected.

The final tests segment is anticipated to exhibit the fastest CAGR of 13.24% from 2023 to 2032. Final reads are increasingly preferred by providers since they produce thorough, reliable results with fewer errors. More final reads and preliminary reads with in-depth radiologists' reports are now being reimbursed by Medicare than typical preliminary reads. Growing competition among teleradiology service providers has resulted in innovations in technology that make it easier for outside radiologists to connect with the sites they scan for, driving teleradiology business entities to produce more final reads. This helps explain the final report segment's significant CAGR over the forecast period. Its lower market size can be attributed to the fact that these studies take more time and hence have higher costs involved.

End-use Insights

Based on end-use, the market is segmented into hospitals, radiology clinics, and ambulatory imaging centers. The hospitals segment held the largest market share of approximately 53% in 2022. In situations of emergency, teleradiology treatments are usually suggested. For instance, teleradiology may assist in a more rapid diagnosis and immediate start of medical care if a patient arrives at a hospital suffering severe head injuries when a neuroradiologist is yet to arrive. Therefore, it is anticipated that the market expansion over the forecast period will be driven by a rise in urgent visits to healthcare facilities. By utilizing teleradiology products and services, hospitals can also reduce the expense of employing radiologists.

U.S. Teleradiology Market Share, By End-use, 2022 (%)

The radiology clinics segment is anticipated to exhibit a CAGR of 12.54% from 2023 to 2032. Radiology clinics are hospitals that specialize in providing diagnostic imaging services. By offering several imaging modalities like X-rays, ultrasounds, CT scans, MRIs, and more, they play a significant part in the healthcare system. To evaluate the images and offer precise diagnoses, radiology clinics work with radiologists. These clinics frequently have cutting-edge imaging technology and are manned by certified radiologic technologists. The knowledge of subspecialized radiologists, who might not be accessible locally, can be helpful to patients.

U.S. Teleradiology Market Segmentations:

By Product 

  • X-rays
  • CT Scans
  • MRI Scans
  • Ultrasound
  • Nuclear Imaging

By Type 

  • Preliminary Tests
  • Final Tests

By End-use 

  • Hospitals
  • Radiology Clinic
  • Ambulatory Imaging Centers

Frequently Asked Questions

The U.S. teleradiology market size was reached at USD 0.88 billion in 2022 and it is projected to hit around USD 2.77 billion by 2032.

The U.S. teleradiology market is growing at a compound annual growth rate (CAGR) of 12.16% from 2023 to 2032.

Key factors that are driving the U.S. teleradiology market growth include increasing focus on patient-centric care, rising need for solutions to reduce healthcare costs, and strong government support.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Product Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on U.S. Teleradiology Market 

5.1. COVID-19 Landscape: U.S. Teleradiology Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape List of Suppliers List of Buyers

Chapter 8. U.S. Teleradiology Market, By Product

8.1. U.S. Teleradiology Market, by Product, 2023-2032

8.1.1 X-rays Market Revenue and Forecast (2020-2032)

8.1.2. CT Scans Market Revenue and Forecast (2020-2032)

8.1.3. MRI Scans Market Revenue and Forecast (2020-2032)

8.1.4. Ultrasound Market Revenue and Forecast (2020-2032)

8.1.5. Nuclear Imaging Market Revenue and Forecast (2020-2032)

Chapter 9. U.S. Teleradiology Market, By Type

9.1. U.S. Teleradiology Market, by Type, 2023-2032

9.1.1. Preliminary Tests Market Revenue and Forecast (2020-2032)

9.1.2. Final Tests Market Revenue and Forecast (2020-2032)

Chapter 10. U.S. Teleradiology Market, By End-use 

10.1. U.S. Teleradiology Market, by End-use, 2023-2032

10.1.1. Hospitals Market Revenue and Forecast (2020-2032)

10.1.2. Radiology Clinic Market Revenue and Forecast (2020-2032)

10.1.3. Ambulatory Imaging Centers Market Revenue and Forecast (2020-2032)

Chapter 11. U.S. Teleradiology Market, Regional Estimates and Trend Forecast

11.1. U.S.

11.1.1. Market Revenue and Forecast, by Product (2020-2032)

11.1.2. Market Revenue and Forecast, by Type (2020-2032)

11.1.3. Market Revenue and Forecast, by End-use (2020-2032)

Chapter 12. Company Profiles

12.1. Virtual Radiologic (vRad).

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Agfa-Gevaert Group.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. ONRAD, Inc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Everlight Radiology.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. 4ways Healthcare Ltd.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. RamSoft, Inc.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. USARAD Holdings, Inc.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Koninklijke Philips N.V.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Matrix (Teleradiology Division of Radiology Partners).

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Medica Group PLC

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Proceed To Buy

USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers